Open DOCX file, 68.99 KB, for
Circular Letter: #17-2-699 Revised Informed Consent for Use of Psychotropic Medications in LTCFs – 2/1/2017
(DOCX 68.99 KB)
This letter describes revised and updated policies that replace the policies and guidance published in the February 1, 2016 Circular Letter: DHCQ 16-2-653